569 related articles for article (PubMed ID: 10503071)
21. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive breast cancer: Part 2. Lobular carcinoma in situ--incidence, presentation, guidelines to treatment.
Swain SM
Oncology (Williston Park); 1989 Mar; 3(3):35-40; discussion 40, 42, 44 passim. PubMed ID: 2561881
[TBL] [Abstract][Full Text] [Related]
23. Morphometric Analysis in the Diagnosis of Low-Grade Ductal and Lobular Carcinoma in Situ of the Breast.
Parra-Herran C; Hope T; Rashed T; Slodkowska E; Lu FI; Nofech-Mozes S
Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):331-8. PubMed ID: 26860008
[TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration cytology of lobular carcinoma in situ.
Ustün M; Berner A; Davidson B; Risberg B
Diagn Cytopathol; 2002 Jul; 27(1):22-6. PubMed ID: 12112810
[TBL] [Abstract][Full Text] [Related]
25. Lobular carcinoma in situ: current concepts and controversies.
Schnitt SJ; Morrow M
Semin Diagn Pathol; 1999 Aug; 16(3):209-23. PubMed ID: 10490198
[TBL] [Abstract][Full Text] [Related]
26. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
27. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
28. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
Andersen J; Blichert-Toft M; Dyreborg U
Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
[TBL] [Abstract][Full Text] [Related]
29. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
30. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
31. Lobular neoplasia: morphology and management.
Jorns J; Sabel MS; Pang JC
Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
[TBL] [Abstract][Full Text] [Related]
32. [Carcinoma in situ. Prognostic factors].
Trojani M
Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
[No Abstract] [Full Text] [Related]
33. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why.
Cohen MA
Radiology; 2004 Jun; 231(3):617-21. PubMed ID: 15163803
[No Abstract] [Full Text] [Related]
34. Ductal lavage in patients undergoing mastectomy for mammary carcinoma: a correlative study.
Brogi E; Robson M; Panageas KS; Casadio C; Ljung BM; Montgomery L
Cancer; 2003 Nov; 98(10):2170-6. PubMed ID: 14601086
[TBL] [Abstract][Full Text] [Related]
35. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
[TBL] [Abstract][Full Text] [Related]
36. Mammography and ultrasound in the diagnosis of contralateral breast cancer.
Rissanen TJ; Mäkäräinen HP; Apaja-Sarkkinen MA; Lindholm EL
Acta Radiol; 1995 Jul; 36(4):358-66. PubMed ID: 7619612
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
Yang G; Guo L; Jin H; Li J; Ding H
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
[TBL] [Abstract][Full Text] [Related]
39. Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ.
Obeng-Gyasi S; Ong C; Hwang ES
Chin Clin Oncol; 2016 Jun; 5(3):32. PubMed ID: 27197512
[TBL] [Abstract][Full Text] [Related]
40. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility.
Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL
AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]